[HTML][HTML] A selective small-molecule inhibitor of c-Jun N-terminal kinase 1

K Yao, YY Cho, AM Bode, A Vummenthala, JG Park… - FEBS letters, 2009 - Elsevier
K Yao, YY Cho, AM Bode, A Vummenthala, JG Park, K Liu, YP Pang, Z Dong
FEBS letters, 2009Elsevier
Indiscriminately suppressing total c-Jun N-terminal kinase (JNK) activity is not an
appropriate strategy because each JNK appears to have a distinct function in cancer,
asthma, diabetes, or Parkinson's disease. Herein, we report that 7-(6-N-phenylaminohexyl)
amino-2H-anthra [1, 9-cd] pyrazol-6-one (AV-7) inhibited JNK1 activity, but not JNK2 or
JNK3. We found that ultraviolet B (UVB) induced c-Jun phosphorylation and sub-G1
accumulation in JNK2−/− murine embryonic fibroblasts, which contain an abundance of …
Indiscriminately suppressing total c-Jun N-terminal kinase (JNK) activity is not an appropriate strategy because each JNK appears to have a distinct function in cancer, asthma, diabetes, or Parkinson’s disease. Herein, we report that 7-(6-N-phenylaminohexyl)amino-2H-anthra[1,9-cd]pyrazol-6-one (AV-7) inhibited JNK1 activity, but not JNK2 or JNK3. We found that ultraviolet B (UVB) induced c-Jun phosphorylation and sub-G1 accumulation in JNK2−/− murine embryonic fibroblasts, which contain an abundance of JNK1, but not JNK2. These results demonstrate that AV-7 is an isoform selective small-molecule inhibitor of JNK1 activity, which might be developed as a therapeutic against diabetes. STRUCTURED SUMMARY: MINT-7148332: JNK3 (uniprotkb:P53779) phosphorylates (MI:0217) c-JUN (uniprotkb:P05412) by protein kinase assay (MI:0424) MINT-7148323: JNK2 (uniprotkb:P45984) phosphorylates (MI:0217) c-JUN (uniprotkb:P05412) by protein kinase assay (MI:0424) MINT-7148314: JNK1 (uniprotkb:P45983) phosphorylates (MI:0217) c-JUN (uniprotkb:P05412) by protein kinase assay (MI:0424)
Elsevier